PDS in the News

Monday, May 3, 2021

Patients who consent to participate in clinical trials are informed that their data will be used for both primary and secondary research purposes. When reassured that data will be anonymized, the overwhelming majority want the value of their data to be maximized through reuse.

Thursday, March 26, 2020

While immunotherapy focuses on medicine at the personal level, many efforts to advance cancer care require data from a lot of different patients.Clinical trials, including those for immunotherapy treatments, are intentionally and meticulously designed to study the specific effects of a specific therapy on a specific type of patient. This level of control is needed to ensure the safety and efficacy of the treatments being studied. 

Friday, March 20, 2020

As precision medicine advances rapidly, so does the need to better communicate the nature and implications of the increasingly more complex, better tailored treatments. 

Technology Networks
Thursday, February 27, 2020

Despite the data explosion in the past 10-15 years, this has largely been “data unrealized” – its value has not been exploited. Subsequent investments in data integration strategies, technology, and analytics have transformed a medley of free-floating data points into an integrated, coherent message.

Monday, November 11, 2019

The eighth symposium co-organized by FDA and Project Data Sphere was hosted by Stanford University School of Medicine. The day was devoted to vibrant discussions around Artificial Intelligence in Tumor Processing – Needs, Requirements, and Challenges with a commitment to advancing image analytics through machine learning algorithms. 

Wednesday, April 17, 2019

NCI Acting Director Dr. Doug Lowy and PDS' Dr. Martin Murphy talk about the organizations' synergy and mutual goals during the Fireside Chat -- a Symposium tradition.

Applied Clinical Trials
Tuesday, January 22, 2019

An open-data, crowdsourced project from Project Data Sphere identified predictors for survival in castration-resistant metastatic prostate cancer through prognostic models that used CDISC-standardized data from the comparator arms of four Phase III clinical trials and enabled 50 independent teams.

Applied Clinical Trials
Thursday, January 17, 2019

Project Data Sphere is an example of the potential of crowdsourced historical clinical trial data. The cancer research initiative allows researchers to submit, collect, and analyze such data for the benefit of research in its online analytics environment.

Thursday, April 26, 2018

The FDA cited collaborations with Project Data Sphere that aim to use medical imaging data to develop algorithms that can better classify tumors, and with the National Cancer Institute on a joint fellowship program to design “digital biomarkers” to use in drug development.

Wednesday, April 4, 2018

Project Data Sphere aims to accelerate research by providing cancer clinical trial data from various sources to “any and all scientists” – and has named pharma industry veteran Bill Louv as its new president to ensure it delivers.